We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Emtricitabine
CAS No.
143491-57-0
Molecular Formula
C8H10FN3O3S
Molecular Weight
247.247
Quality Standard
98% up, Medicine Grade
Appearance
White powder
COA of Nonapeptide-1
TEST
SPECIFICATION
RESULTS
Appearance
White to off-white powder
White powder
Identification
By chiral HPLC: the retention time of the main peak corresponds within 2.0% to that of the cis-(-)-EMTB reference standard
< 0.1%
Conforms
By IR: Consistent with the reference standard
Conforms
Clarity of solution (1% w/v in water)
Clear, essentially free of visible particles
Conforms
Water Content
NMT 0.5%
< 0.1%
Heavy Metals as lead
NMT 20 ppm
< 10 ppm
Residue on ignition
NMT 0.2%
0.1%
Bulk density
Report data
0.20 g/mL
Particle size by laser light scattering
d50 ≤ 30
24
d90: 45~75
51
Residual solvent
Methanol ≤ 0.20%
ND
Isopropyl acetate ≤ 0.20%
ND
l-propanol ≤ 1.00%
0.05
Any unspecified solvent ≤ 0.10 or ≤ the premitted daily exposure specified by ICH Q3C
ND
EMTB-Dioxolane
≤ 0.70%
ND
EMTB-Carboxylic acid
≤ 0.50%
ND
EMTB-Disulfide
≤ 0.30%
ND
Emtb sulfoxides
≤ 0.15%
0.05%
Any unspecified impurity by HPLC
≤ 0.10%
Trace
Total impurities by
≤ 1.0%
0.1%
Assay by HPLC
98.0~102.0 (Dried basis)
100.1
98.0~102.0 (Anhydrous basis)
100.1
Drug content factor(Report data)
0.999
cis-(-)chiral purity by HPLC(%)
cis-(-)-EMTB ≥ 98.5
100.0
cis-(+)-EMTB (report data)
Trace
trans-(-)-EMTB (report data)
ND
trans-(+)-EMTB (report data)
ND
CONCLUSION
LOT MEETS SPECIFICATION
Usage
Function of Emtricitabine
Emtricitabine is a new type of nucleoside reverse transcriptase inhibitor that has antiviral activity against HIV-1, HIV-2 and HBV. This product is phosphorylated into cellular active 5'-triphosphate after oral administration. The 5'-triphosphate enters the viral DNA backbone and binds to the backbone, resulting in chain termination, thereby inhibiting HIV-1 reverse transcriptase and HBV DNA polymerase activity.
Emtricitabine does not affect the liver microsomal enzyme P450 enzyme system, and does not produce drug interactions mediated by it. It is used in combination with tenofovir, indinavir, famciclovir, and stanvudine, with almost no pharmacokinetics influences.
Our advantages of Emtricitabine (CAS: 143491-57-0) :
1. Quality: 99% up, full test report.
2. Documents: DMF, our facotory pass FDA audit with Zero defect. passing MCC in South African,
3. Large capacity & stock :80MT per year with 1000kg in stock for prompt shipment
4. Better payment terms : We can make use of Export Credit Insurance after confirming yr credit report accepted by Sinosure.
5. Various shipping ways for your choice : by air./ by sea / by courier (DHL/FedEx).
6. we also provide TDF, TAF, Efavirenz, that used togher with Emtritabine as the Compound Preparation to treat HIV.
The main Compound Preparation:
TDF+Emtricitabine and TDF+Emtricitabine+Efavirenz.